Original Article

The Effect of Aminophylline on Renal Colic: A Randomized Double Blind Controlled Trial

Authors: Hooman Djaladat, MD, Parvin Tajik, MD, Salman Abbasi Fard, MD, Sara Alehashemi, MD

Abstract

Objective: To evaluate the efficacy of aminophylline infusion as a painkiller compared with placebo in patients with acute renal colic.


Patients and Methods: From March to August 2005, 141 patients with clinical renal colic, who were under 60 years of age, had no history of heart or hepatic failure, asthma, theophylline or beta blocker use, reaction to methylxantines, pregnancy or breast feeding, and were not prescribed spasmolytic or analgesics, entered our study. They were randomly assigned to receive either 375 mg of aminophylline or placebo infusion under double blind conditions. Pain intensity was recorded using a visual analog scale (VAS), before drug administration and 30 and 60 minutes afterwards. The drug effectiveness was defined as ≥40% decrease in pain intensity 60 minutes after the onset of infusion, without exacerbation during the following 4 hours.


Results: Seventy patients received aminophylline; it was effective in 45 (64%; 95% confidence interval 52–75%). Alternatively, placebo was effective in 12 of 71 control patients (17%; 95% confidence interval 9–28%); (P < 0.001). Thirty and 60 minutes after administration, aminophylline reduced pain by 24% and 39% respectively, as compared with 6% and 8% pain reduction in the placebo group.


Conclusion: This prospective study provides remarkable information about the efficacy of aminophylline on pain relief and decreasing narcotic usage in symptomatic urinary calculi. It is safe, inexpensive, with minute side effects and can be considered a good alternative or additive to narcotic analgesics in the management of renal colic.


Key Points


* The most common symptom of pelvic ureterolithiasis is pain.


* Parenteral administration of narcotic analgesics has been assumed to be the treatment of choice in renal colic patients.


* Aminophylline, an inhibitor of phosphodiesterase, results in smooth muscle relaxation through an increase in cAMP level.


* In a controlled trial, aminophylline was showed to decrease pain intensity significantly in patients with renal colic.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Gulmi F, Felsen D, Vaughan ED. Pathophysiology of urinary tract obstruction. In: Walsh P et al, eds. Campbell's Urology, 8th edition. Philadelphia, Pennsylvania. W. B. Saunders; 2002; pp. 411–462.
 
2. Romics I, Molnar DL, Timberg G, et al. The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones. BJU International 2003;92:92–96.
 
3. Menon M, Resnick MI. Urinary lithiasis: Etiology, Diagnosis and Medical Management. In: Walsh P, et al, eds. Campbell's Urology, 8th edition. Philadelphia, Pennsylvania. W. B. Saunders; 2002; pp. 3227–3305.
 
4. Undem BJ, Lichtenstein LM. Drugs used in the treatment of asthma. In Hardman JG, Limbird LE, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 10th edition. New York, New York: McGraw-Hill; 2001;733–754.
 
5. Eray O, Cubuk MS, Oktay C, et al. The efficacy of urinalysis, plain films, and spiral CT in ED patients with suspected renal colic. Am J Emerg Med 2003;21:152–154.
 
6. Porena M, Guiggi P, Balestra A, et al. Pain killers and antibacterial therapy for kidney colic and stones. Urol Int 2004;72:S34–S39.
 
7. Edwards JE, Meseguer F, Faura C, et al. Single dose dipyrone for acute renal colic pain. Cochrane Database Syst Rev. 2002;4:CD003867.
 
8. Tozawa K, Yasui T, Okada A, et al. Optimal treatment of urolithiasis pain. Hinyokika Kiyo2004;50:569–571.
 
9. Holdgate A, Pollock T. Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic. Cochrane Database Syst Rev 2005;18:CD004137.
 
10. El-Sherif AE, Salem M, Yahia H, et al. Treatment of renal colic by desmopressin intranasal spray and diclofenac sodium. J Urol 1995;153:1395–1398.
 
11. Jackson EK. Vasopressin and other agents affecting the renal conservation of water. In Hardman JG, Limbird LE, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 10thedition. New York, New York. McGraw-Hill; 2001; pp. 789–808.
 
12. Katevue K, Kanto J, Kleimola T. Aminophylline in ureterolithiasis: preliminary report. Int J Clin Pharmacol Ther Toxicol 1981;19:512–513.
 
13. Stankov G, Schmieder G, Zerle G, et al. Double-blind study with dipyrone versus tramadol and butyl scopolamine in acute renal colic pain. World J Urol 1994;12:155–161.